These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7745107)

  • 61. Correlation of Serum Ferritin and Liver Iron Concentration with Transient Liver Elastography in Adult Thalassemia Intermedia Patients with Blood Transfusion.
    Atmakusuma TD; Lubis AM
    J Blood Med; 2021; 12():235-243. PubMed ID: 33883962
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of iron-chelator deferiprone on the in vitro growth of staphylococci.
    Kim CM; Shin SH
    J Korean Med Sci; 2009 Apr; 24(2):289-95. PubMed ID: 19399272
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Iron chelation therapy.
    Hoffbrand AV; Wonke B
    J Intern Med Suppl; 1997; 740():37-41. PubMed ID: 9350180
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Orally active iron chelators.
    Merson L; Olivier N
    Blood Rev; 2002 Jun; 16(2):127-34. PubMed ID: 12127956
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Changes in transferrin saturation after treatment with the oral iron chelator deferiprone in patients with iron overload.
    al-Refaie FN; De Silva CE; Wonke B; Hoffbrand AV
    J Clin Pathol; 1995 Feb; 48(2):110-4. PubMed ID: 7745107
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of deferiprone in patients with β-thalassaemia: impact of splenectomy and iron status.
    Limenta LM; Jirasomprasert T; Jittangprasert P; Wilairat P; Yamanont P; Chantharaksri U; Fucharoen S; Morales NP
    Clin Pharmacokinet; 2011 Jan; 50(1):41-50. PubMed ID: 21028920
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Timed non-transferrin bound iron determinations probe the origin of chelatable iron pools during deferiprone regimens and predict chelation response.
    Aydinok Y; Evans P; Manz CY; Porter JB
    Haematologica; 2012 Jun; 97(6):835-41. PubMed ID: 22180427
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical evaluation of the oral iron chelator deferiprone for the potential treatment of iron overload in bird species.
    Whiteside DP; Barker IK; Mehren KG; Jacobs RM; Conlon PD
    J Zoo Wildl Med; 2004 Mar; 35(1):40-9. PubMed ID: 15193072
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ; Aldouri MA; Hoffbrand AV; Barr J; Wonke B; Kourouclaris T; Sheppard L
    Br Med J (Clin Res Ed); 1987 Dec; 295(6612):1509-12. PubMed ID: 3122880
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Zinc concentration in patients with iron overload receiving oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one or desferrioxamine.
    al-Refaie FN; Wonke B; Wickens DG; Aydinok Y; Fielding A; Hoffbrand AV
    J Clin Pathol; 1994 Jul; 47(7):657-60. PubMed ID: 8089225
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The distribution of iron between the metal-binding sites of transferrin human serum.
    Williams J; Moreton K
    Biochem J; 1980 Feb; 185(2):483-8. PubMed ID: 7396826
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Site specificity of iron removal from transferrin by alpha-ketohydroxypyridine chelators.
    Kontoghiorghes GJ; Evans RW
    FEBS Lett; 1985 Sep; 189(1):141-4. PubMed ID: 4029396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A serum ferritin assay for prevalence studies of iron deficiency.
    Flowers CA; Kuizon M; Beard JL; Skikne BS; Covell AM; Cook JD
    Am J Hematol; 1986 Oct; 23(2):141-51. PubMed ID: 3529940
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron.
    Pootrakul P; Josephson B; Huebers HA; Finch CA
    Blood; 1988 Apr; 71(4):1120-3. PubMed ID: 3355890
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of an HPLC method for measuring orally administered 1-substituted 2-alkyl-3-hydroxypyrid-4-one iron chelators in biological fluids.
    Goddard JG; Kontoghiorghes GJ
    Clin Chem; 1990 Jan; 36(1):5-8. PubMed ID: 2297936
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial.
    Agarwal MB; Gupte SS; Viswanathan C; Vasandani D; Ramanathan J; Desai N; Puniyani RR; Chhablani AT
    Br J Haematol; 1992 Oct; 82(2):460-6. PubMed ID: 1419829
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.